Insights

Choate Represents Rob Hale in $6.1B Acquisition of Boston Celtics

Choate represented Boston-businessman Rob Hale and his affiliate companies, Copley Equity Partners and Fox Rock Capital, in the $6.1B acquisition of the Boston Celtics.

31 Choate Attorneys Named to Massachusetts Supreme Judicial Court 2023 Pro Bono Honor Roll

31 Choate attorneys have been recognized by the Massachusetts Supreme Judicial Court’s Pro Bono Honor Roll for distinguished service by providing volunteer legal services for those most in need.

Choate Represents Venminder in Acquisition by Ncontracts

Choate represented Venminder, a unified platform for managing third-party risk, in its acquisition by Ncontracts, a leading provider of integrated compliance, risk, and vendor management solutions to the financial services industry.

M/C Partners Announces Growth Investment in AccessParks

Choate represented M/C Partners in a significant growth investment in AccessParks, which provides high-performance broadband connectivity to RV parks, national and state parks, and manufactured housing communities across the United States.

Hallmark Health Care Solutions Receives Significant Investment from Summit Partners 

Choate represented Enhanced Healthcare Partners and its portfolio company Hallmark Health Care Solutions in connection with a significant investment by Summit Partners.

Guidepost Growth Equity Makes $25M Investment in Intellum

Choate represented Guidepost Growth Equity, a leading core growth equity firm that partners with entrepreneur-led application and infrastructure software, and tech-enabled and data services companies, in its $25M minority growth equity investment in Intellum, a leading enterprise learning management system.

Enhanced Healthcare Partners Makes Strategic Growth Investment in Janus

Choate represented Enhanced Healthcare Partners in its strategic growth investment in Janus, a leading provider of healthcare revenue cycle management (RCM) technology.

CytoTronics Receives $9.25M in Initial Seed Funding

Choate represented CytoTronics in its $9.25 million initial seed funding, which was led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures) and institutional investors.